Supernus Pharmaceuticals
UnverifiedManufacturerRockville, MDFounded 2005Nasdaq: SUPN
Overview
Supernus Pharmaceuticals is a Rockville, Maryland biopharmaceutical company focused on central nervous system diseases, with approved treatments for ADHD, Parkinson's disease, postpartum depression, epilepsy, migraine, cervical dystonia and chronic sialorrhea. It runs three US sales forces: Parkinson's, ADHD and postpartum depression. It acquired Sage Therapeutics on 31 July 2025 and in August 2026 agreed a merger of equals with Indivior; Supernus stockholders approved it on 15 October 2026 and it had not closed at the time of this build.
Hiring snapshot
Hiring by specialty
Open roles
Newest first, from Supernus Pharmaceuticals’s careers page.
- Inside Sales Representative PSYCHRockville, Maryland4d ago$45k–$57k
- Professional Sales Representative - New Brunswick, NJ (ADHD)New Brunswick, New Jersey9d ago$75k–$90k
- Professional Sales Representative - Raleigh West, NC (ADHD)Raleigh, North Carolina9d ago$75k–$90k
- Territory Sales Manager - Birmingham, AL (Postpartum Depression)Birmingham, Alabama9d ago$100k–$110k
- Senior Territory Sales Manager - Indianapolis, IN (Parkinson's)Capitol, Indiana9d ago$120k–$130k
- Professional Sales Representative - Poughkeepsie, NY (ADHD)Poughkeepsie, New York9d ago$75k–$90k
Divisions
Division information is pending company verification.Once Supernus Pharmaceuticals claims its page, you will see each division, who it calls on and how it pays.
Claim your pageMore from Supernus Pharmaceuticals
These sections fill in when Supernus Pharmaceuticals claims and verifies its page.